Miller, S;
Matharu, MS;
(2017)
The Use of Electroceuticals and Neuromodulation in the Treatment of Migraine and Other Headaches.
In: Majid, A, (ed.)
Electroceuticals: Advances in Electrostimulation Therapies.
(pp. 1-33).
Springer: Cham, Switzerland.
Preview |
Text
Matharu_Chapter-electroceuticals_final.pdf - Accepted Version Download (488kB) | Preview |
Abstract
Over recent years there has been increasing interest in the role of neurostimulation in the treatment of headache disorders. Currently both peripheral and central neuromodulation devices are available although evidence to support their use is still limited. Both non-invasive and invasive devices can be used for neurostimulation. Non-invasive peripheral stimulation options include supra-orbital stimulation (Cefaly® device) and vagal nerve stimulation (gammaCore® device), while invasive peripheral stimulation options include occipital nerve stimulation and sphenopalatine ganglion stimulation. Non-invasive central neurostimulation option involves single pulse transcranial magnetic stimulation (SpringTMS® device), while invasive central neurostimulation can be carried out using ventral tegmental area deep brain stimulation. Neurostimulation therapies offer a promising approach to otherwise medically intractable or difficult to treat headache disorders with each device having specific roles within the treatment pathway.
Archive Staff Only
 |
View Item |
